Phase 2 N=30 Randomized Treatment

A Prospective Comparison of Ultrasound-Guided Percutaneous Platelet-Rich Plasma Injection

Tendinosis · Tendinitis

Bottom Line

View on ClinicalTrials.gov: NCT01600326 ↗

Enrolled (actual)

Serious AEs

3.3%

Results posted

Apr 2017

Primary outcome: Primary: Pain Level and Interference With Activity — 16.8; 25.5; 15.2; 19.4 units on a scale — p=<0.0001

Study Design & Population

Study type: Interventional
Phase: Phase 2
Interventions: Tenotomy (no injection) (Procedure); Ultrasound guided platelet rich plasma injection (Drug)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: University of Michigan
Primary completion: Jul 2015

Outcome Measures

Outcome	Result	p-value
PRIMARY Pain Level and Interference With Activity	16.8; 25.5; 15.2; 19.4	<0.0001 sig
SECONDARY Number of Participants Showing Symptomatic Improvement as Assessed in Patient Chart	10; 11	>.99

Summary

The purpose of this study is to determine the effectiveness of various treatment soft tendinosis also known as tendinitis.

Eligibility Criteria

Inclusion Criteria

Adult subjects with a diagnosis of tendinosis of the hip.
Adult subjects who have been referred to Dr. Jacobson for the treatment of tendinosis by tenotomy.

Exclusion Criteria

pregnancy
risk of bleeding due to anticoagulant medication
presence of malignancy
steroid injection less than 3 months before enrollment

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01600326). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.